What is Aclaris Therapeutics's EV / sales?

Aclaris Therapeutics (ACRS) reported EV / sales of 51.1× in Q1 2026.

How has Aclaris Therapeutics's EV / sales changed year-over-year?

Aclaris Therapeutics's EV / sales increased by 560.0% year-over-year, from 7.7× to 51.1×.

What is the long-term trend for Aclaris Therapeutics's EV / sales?

Over 5 years (2020 to 2025), Aclaris Therapeutics's EV / sales has grown at a -8.0% compound annual growth rate (CAGR), from 59.9× to 39.4×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

Aclaris Therapeutics ACRS EV / sales

EV / sales at other companies

IncyteINCY

2.9×+0.6×

Upstream Bio, Inc.UPB

118.7×+6.0×

Avalo TherapeuticsAVTX

-127.1×-128×

Shattuck Labs, Inc.STTK

372.6×+370×

Kymera TherapeuticsKYMR

130.9×+101×

CytomX TherapeuticsCTMX

27.9×+27.8×

Other financials

Income statement

See full

Revenue$2.0M+37.2%

Gross profit$1.6M+68.7%

Operating income-$22.2M-22.7%

Net income-$19.8M-31.4%

EPS (diluted)-$0.15-25.0%

Balance sheet

See full

Cash & equivalents$28.7M-5.6%

Total debt$2.0M-20.1%

Total equity$143.6M-0.3%

Total assets$198.7M+0.3%

Cash flow

See full

Operating cash flow-$18.1M-39.0%

CapEx$13.0K-69.8%

Free cash flow-$18.2M-38.6%

Valuation

See full

Market cap$685.75M+337%

Enterprise value$659.07M+410%

P/S82×+73.1×

Profitability

See full

Gross margin76.3%-9.7pp

Operating margin-961.9%+259pp

Net margin-832.6%+132pp

FCF margin-624.9%—

Returns & leverage

See full

Return on equity-48.4%-15.4pp

Debt / equity0×0.0×

Current ratio4×-1.0×

Where this comes from

Calculated from Aclaris Therapeutics’s reported figures.

enterprise value/total revenue=51.1×

Based on the most recent quarter.

The official record: Aclaris Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Aclaris Therapeutics's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Aclaris Therapeutics's EV / sales?: Aclaris Therapeutics (ACRS) reported EV / sales of 51.1× in Q1 2026.
How has Aclaris Therapeutics's EV / sales changed year-over-year?: Aclaris Therapeutics's EV / sales increased by 560.0% year-over-year, from 7.7× to 51.1×.
What is the long-term trend for Aclaris Therapeutics's EV / sales?: Over 5 years (2020 to 2025), Aclaris Therapeutics's EV / sales has grown at a -8.0% compound annual growth rate (CAGR), from 59.9× to 39.4×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.